Associate Professor Amy Reynolds

Associate Professor Amy Reynolds is currently an Australian Research Council Discovery Early Career Researcher Award recipient, funded to explore the relationship between shift work, sleep disorders and safety. She is a clinical epidemiologist and intern psychologist with 15 years of sleep research expertise, particularly in the relationships between non-standard work schedules (particularly shift work), health and safety. She is the current co-lead of the insomnia, shift work and body clock disruption theme at Flinders University's Health and Medical Research Institute, at FHMRI Sleep Health (formerly Adelaide Institute of Sleep Health).

Most recently, Amy's shift work and sleep psychology expertise was showcased in SBS's multi-award winning documentary, Australia's Sleep Revolution with Dr Michael Mosley. She was named the Australian Institute of Policy and Science's Young Tall Poppy of the Year (SA) in 2024.

Her key research focus is the experiences of shift workers living with sleep problems, many of whom are undiagnosed and untreated for extended periods of time. These sleep disorders include obstructive sleep apnoea, insomnia, and shift work disorder. 

A/Professor Reynolds works closely with industry partners, and has expertise working with emergency services, mining and minerals, transport and healthcare sectors. Her research focusses on solution-based approaches for our workforce who need to work non-standard schedules, and working in partnership with industry and workers to identify feasible solutions which support healthy workforces. She is passionate about working collaboratively with shift workers to re-design a health system which sees them able to access timely and effective sleep disorder care in Australia, with a big focus on ensuring that young shift workers receive the care they need for their sleep. 

In addition to her own research interests, A/Professor Reynolds is a patient research partner, working alongside experts in the Rheumatology field to amplify the voice of patients living with autoimmune disease. She currently serves as an Australian representative for the BMJ's International Patient Advisory Panel.